The Biden administration on Monday withdrew a Trump-era rule tying U.S. drug payments to cheaper foreign rates amid an ongoing government push to curb rising pharmaceutical costs.
The Trump-era rule (RIN 0938-AT91) matched Medicare reimbursement for drugs administered in doctors’ offices—which are usually expensive and often for serious illnesses—to lower prices paid in other countries. The HHS, under President Joe Biden, said it was exploring other options to improve the quality and cost of care for beneficiaries.
The rule was finalized in 2020, but it was blocked by federal judges and paused by Biden.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.